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Longitudinal Effect of Stroke on Cognition: A Systematic Review
Eugene YH Tang, MSc; Obreniokibo Amiesimaka, BSc; Stephanie L Harrison, PhD; Emma Green, MSc; Christopher Price, MD;
Louise Robinson, MD; Mario Siervo, PhD; Blossom CM Stephan, PhD
Background-—Stroke is associated with an increased risk of dementia; however, the impact of stroke on cognition has been found
to be variable, such that stroke survivors can show decline, remain stable, or revert to baseline cognitive functioning. Knowing the
natural history of cognitive impairment after stroke is important for intervention. The aim of this systematic review is to investigate
the longitudinal course of cognitive function in stroke survivors.
Methods and Results-—Three electronic databases (Medline, Embase, PsycINFO) were searched using OvidSP from inception to
July 15, 2016. Longitudinal studies with ≥2 time points of cognitive assessment after stroke were included. In total, 5952 articles
were retrieved and 14 were included. There was a trend toward significant deterioration in cognitive test scores in stroke survivors
(8 studies). Cognitive stability (3 studies) and improvement (3 studies) were also demonstrated, although follow-up time tended to
be shorter in these studies. Variables associated with impairment included age, ethnicity, premorbid cognitive performance,
depression, stroke location, and history of previous stroke. Associations with APOE*E4 (apolipoprotein E with the E4 allele) allele
status and sex were mixed.
Conclusions-—Stroke is associated with an increased risk of cognitive decline, but cognitive decline is not a consequence. Factors
associated with decline, such as sociodemographic status, health-related comorbidity, stroke history, and clinical features could be
used in models to predict future risk of dementia after stroke. A risk model approach could identify patients at greatest risk for
timely intervention to reduce the frequency or delay the onset of poststroke cognitive impairment and dementia. ( J Am Heart
Assoc. 2018;7:e006443. DOI: 10.1161/JAHA.117.006443.)
Key Words: cognition • cognitive impairment • dementia • risk factors/global assessment • stroke
S troke is the second most common cause of acquiredcognitive impairment, which predisposes patients toward
institutionalization, disability, increased mortality, and poorer
quality of life.1–3 With an aging population and a decline in
mortality after stroke,4 the rates of poststroke cognitive
impairment will increase. Despite being as common as other
neurological deficits, such as motor and sensory, cognitive
impairment is often overlooked in the follow-up of stroke
survivors unless they have progressed to dementia.5 This may
well be because these patients are able to maintain some
level of personal independence despite poor cognitive
recovery.6
It has been found that stroke survivors may show no
cognitive deficits or may decline, initially decline and then
improve, remain stable, or progress to dementia over time.7,8
Mixed findings may be related to differences in the cognitive
tests used and test timing, history of previous stroke, stroke
location, large- and small-vessel disease, population sample
(clinical versus population based), ethnicity, and the pres-
ence of neurodegenerative pathology.9 Nevertheless, it is
also possible that the initial poststroke cognitive state may
reflect prestroke cognitive decline10 or delirium.11 There is a
drive toward detecting long-term cognitive outcomes after
stroke to explore prevention; however, a preferred testing
strategy is lacking, making cross-study comparison
difficult.12
The aim of this systematic review was to assess the
longitudinal pattern of cognitive function in stroke survivors
and to determine those factors associated with change over
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time. Recognizing the natural history of cognitive impairment
after stroke is vital for informing early treatment and
preventative strategies.
Methods
The data, analytic methods, and study materials will be made
available to other researchers for purposes of reproducing the
results or replicating the procedure. This material can be
made available by the corresponding author on reasonable
request.
Search Strategy and Selection Criteria
This systematic review was undertaken in accordance with
the PRISMA (Preferred Reporting Items for Systematic
Reviews and Meta-Analyses) statement.13 The review was
registered with PROSPERO (CRD42014015018). Three elec-
tronic databases—Medline, Embase, and PsycINFO—were
searched using OvidSP from inception to July 15, 2016;
searches were restricted to human studies and articles
published in English. Predefined and Boolean search terms
were used, including stroke, (cognit* or neuropsych*), and
(progress* or longitudinal or decline or prospective). Longitu-
dinal studies with ≥2 time points of cognitive assessment
after stroke were included. No distinction was made regarding
the sampling framework (clinic, hospital, or population based),
the number of strokes, or the timing of cognitive assessments
after stroke or cognitive battery used. Studies in which
baseline and subsequent incident stroke cases found at
follow-up were analyzed together were included. No distinc-
tion was made regarding the mechanism of stroke, and
studies were not excluded if stroke was not confirmed using
neuroimaging. All participants were adults who were aged
≥50 years and free from dementia. Randomized controlled
trials and cognitive rehabilitation studies were excluded.
Studies in which the only outcome was a diagnosis of
dementia were excluded because this was the subject of a
previous review.14 Studies were excluded if change in
cognitive function over time in the stroke group was not
reported (ie, studies that only compared cognitive outcomes
in stroke patients versus controls were excluded). Studies
were also excluded if they reported percentages of decline
rather than actual test scores or did not report statistical
comparison of change in cognitive performance over time.
Four authors (O.A., E.Y.H.T., E.G., and S.L.H.) indepen-
dently searched the article titles and abstracts. If the article
could not be rejected with certainty based on title or abstract
alone, then the full text of the article was obtained.
Discrepancies between authors were resolved by consensus,
and if this was not possible, then they were resolved by a third
author (B.C.M.S.). Four authors (O.A., E.Y.H.T., E.G., and
S.L.H.) carried out evaluation of full-text articles. Consensus
or a third author resolved disagreements. The reference lists
of the full-text articles and any relevant reviews were
searched for potential eligible references.
Data Extraction
Data extracted included study design, sample size, demo-
graphic characteristics, inclusion or exclusion criteria, defini-
tion of stroke, cognitive test battery, and results. Three
authors (E.Y.H.T., S.L.H., and E.G.) extracted data indepen-
dently, and any discrepancies were resolved through consen-
sus or discussion with a third author (B.C.M.S.). Because of
the heterogeneity in the study design (eg, variation in follow-
up time, cognitive test battery used), a meta-analysis was not
possible.
Results
Figure shows the results of the electronic search and article-
selection process. The search identified 9365 articles, of
which 3413 were duplicates and thus removed. After
reviewing titles and abstracts, 238 articles were retained for
full-text review. The main reasons for exclusion were that the
study population age was <50 years, cognitive measures
were not reported, and a cross-sectional design was used.
Fourteen articles met the inclusion criteria.
Study Characteristics
Characteristics of the included studies and detailed cognitive
outcomes are shown in Tables S1 and S2, respectively. The
number of participants at baseline ranged from 5015 to
1187.16 Follow-up ranged from 3 weeks17 to 6 years.15,18,19
The cohorts included stroke-specific populations17,20–23 and
Clinical Perspective
What Is New?
• Cognitive outcome following a stroke is dependent on
sociodemographic, health, and stroke-related risk factors
and the timing of cognitive assessment.
What Are the Clinical Implications?
• Poststroke patients need to have their cognitive function
followed up over time to ensure that cognitive decline is
noted early.
• Known risk factors associated with poststroke cognitive
decline could be incorporated into risk scores to ensure
timely detection of poststroke cognitive decline.
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population-based studies.15,16,18,19,24–28 The majority of stud-
ies were conducted in the United States (n=4),16,18,25,26
followed by the United Kingdom (n=2),20,27 Israel (n=2),22,23
the Netherlands (n=2),15,24 Germany (n=1),19 India (n=1),28
Norway (n=1),21 and Japan (n=1).17 Stroke case ascertain-
ment included hospital-based diagnosis,20–23,27 self-
report,15,25 general practitioner records,19 self-report
confirmed through medical records and/or expert
review,16,18,24,26,28 and not specified.17 Only 2 studies used
magnetic resonance imaging data.22,23
Cognitive Assessments
The Mini Mental State Examination (MMSE; total,16,17,21,24,28
subtests scores,26 andmodifiedMMSE [3MSE]25) was themost
commonly used cognitive assessment. Other batteries for
assessing global cognitive function included the Montreal
Cognitive Assessment (MoCA),22,23 the Cambridge Cogni-
tive Assessment (CAMCOG),27 the revised CAMCOG
(CAMCOG-R),20 and the Repeatable Battery for the Assessment
of Neuropsychological Status (RBANS).21 Domain-specific
Records identified through OvidSp 
(Selecting Medline, Embase and 
PsycINFO) 
(n=9365)
Sc
re
en
in
g
In
cl
ud
ed
El
ig
ib
ili
ty
Id
en
tif
ic
at
io
n
Duplicates 
(n=3413 duplicates removed)
Records screened 
(n=5952)
Full-text articles assessed 
for eligibility 
(n=238)
Full-text articles excluded, with 
reasons 
(n=224)
n=93 Age outside range
n=26 Cross-sectional analysis of cognitive 
data
n=22 Tested pre- vs. post-stroke cognition 
or had less than 2 measures of cognition 
post-stroke
n=41 Outcome not cognitive change scores 
(e.g., looked at incident dementia)
n=10 Commentary/reviews
n=6 No statistical comparison across 
cognitive change scores
n=6 RCT/Rehabilitation studies
n=5 Cognition used to predict incident 
stroke
n=5 Not a stroke specific sample 
n=5 Sample were demented at baseline 
n=4 Didn’t include results for cognitive 
outcomes
n=1 Protocol
Studies included in 
qualitative synthesis 
(n=14)
Figure. Flow diagram showing article selection. RCT indicates randomized controlled trial.
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cognitive tests included the Auditory Verbal Learning Test
(immediate and delayed recalled),24 the Alphabet Coding
Task,15,24 East Boston Test,16 the Symbol Digits Modalities
Test,16 subtests of the neuropsychological test battery of the
Consortium to Establish a Registry for Alzheimer’s Disease,19 2
subsets of Raven’s Coloured Progressive Matrices,15 and the
word-list delayed recall of the Spanish and English Verbal
Learning Test.25 The computerized neuropsychological assess-
mentNeuroTraxwasusedby2studiesbutinthesamecohort.22,23
Study Sampling Framework
The majority of cohorts were population based
(n=8),15,16,18,19,24–26,28 although 5 studies were hospital
based,17,20–23 and the sampling framework was unclear in 1
study.27 The studies demonstrating cognitive decline tended
to be population-based cohorts with longer follow-up (3
years28 to 6 years15,18). Studies demonstrating cognitive
recovery were all hospital-based cohorts with shorter follow-
up (3 weeks17 to 13 months21). Cognitive outcomes were
also reported in separate studies from the same population in
2 cohorts: a hospital-based cohort (Tel Aviv Brain Acute
Stroke Cohort)22,23 and a population-based cohort (Longitu-
dinal Aging Study Amsterdam).15,24
Cognitive Function After Stroke
The impact of stroke on cognitive function over time was
mixed as shown in the Table.
Global cognitive function
Most studies (n=12) included a measure of global cognitive
function. Of these, 3 studies16,18,28 reported significant
decline (follow-up: 3–6 years), 3 studies15,21,25 reported
no change (follow-up: 13 months to 6 years), and 3
studies17,20,21 reported significant improvement (follow-up: 3
weeks to 13 months) over time. In stratified analyses (4
studies), it was found (1) that although there was no
significant decline in global function (3MSE score), over 3
years of follow-up in the whole sample with sex-stratified
analysis, both men and women showed significant changes in
3MSE errors (worse in men than women, but no significant
sex differences)25; (2) that stroke patients with slower
physical performance, measured using the Timed Up and Go
test, performed significantly worse on a computerized global
cognitive test battery compared with stroke patients with
faster physical performance (follow-up duration: 2 years)22;
(3) that stroke patients with comorbid depression performed
significantly worse on global cognitive scores compared with
stroke patients without depression (follow-up duration:
2 years)23; and (4) that there was no significant difference
in CAMCOG scores when stroke patients were stratified by
homocysteine levels (follow-up duration: 27 months).27
Memory
Six studies included tests of memory.15,19,21,24–26 Of these, 2
reported significant decline including impairments in immediate
anddelayed recall (follow-up: 6 years)15 and visualmemory (follow-
up: 5 years).29 Four studies reported no significant change in
measures of verbal memory (follow-up: >3 years),25 immediate
memory (follow-up: 13 months),21 or immediate and delayed recall
(follow-up:3.1–4.5 years).19,24Onestudy foundan improvement in
delayed memory over 13 months of follow-up.21 In stratified
analyses, 1 study reported significant decline in memory for those
with higher Geriatric Depression Scale (GDS) scores.23 One study
reported a significant decline in memory over 5-year follow-up and
was also found to be strongest for men compared with women.26
Nonmemory
Five studies included nonmemory tests.15,19,21,24,26 One study
reported a significant decline in information processing speed
over6yearsof follow-up.15 Three studies reportednochanges in
nonmemory performance including measures of abstract rea-
soning,26 visuospatial ability,26 verbal fluency,19 attention,21
informationprocessingspeed,24and languageperformance21,26
(follow-up: 13 months to 5 years). One study reported signifi-
cant improvement in executive function over 3 months follow-
up,20 and another reported significant improvements in visu-
ospatial/constructional performance over 13 months follow-
up.21 In stratified analysis, 1 study reported significant declines
in executive function and visuospatial domains for those with
higher admission and 6 month GDS scores; attention also
declined in those who had higher GDS scores at 6 months.23 A
further study reported a significant decline in abstract/visu-
ospatial scores in patientswhowere negative versus positive for
APOE*E4 (apolipoprotein E with the E4 allele).26
Risk Factors for Poststroke Cognitive Decline
Risk factors for cognitive impairment included ethnicity (greater
risk in black patients compared with white patients),16
depression,23,28 increased age,22,23,28 sex (mixed results25,28),
APOE*E4 status (mixed findings21,24,26), poorer cognitive perfor-
mance after stroke,22 stroke location (left and right hemi-
sphere),18 and a previous history of stroke.21 Findings for sex
weremixed: 1 study found no sex differences,25 1 found a greater
risk of global impairment inwomen,28 andanother found agreater
risk of decline in memory in men.26 In 1 study, systolic blood
pressure was not associated with global cognitive function
>3 years after stroke in either men or women.25
Discussion
In this systematic review, the effect of stroke on longitudinal
changes in cognitive function before a diagnosis of dementia
DOI: 10.1161/JAHA.117.006443 Journal of the American Heart Association 4
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was found to be mixed depending on the cognitive domain
tested and methodology factors (eg, follow-up time). Further-
more, risk factors traditionally associated with cognitive
decline, including APOE*E4 status24,26 and systolic blood
pressure level,25 did not have the same expected effect in
stroke-specific samples. Accurate identification of stroke
survivors at highest risk of cognitive decline is important and
could be used to identify people for early intervention and
participation in clinical trials.
Regarding global cognitive function, the majority of studies
reported decline,16,18,22,23,25,28 whereas 5 reported no
change.15,21,24,25,27 In contrast, 3 studies utilizing different
cognitive batteries (MMSE17, CAMCOG-R,20 and RBANS21)
reported recovery. Recovery as measured by MMSE and
CAMCOG-R could be due to a combination of the small
sample size of the study (57 patients17 and 83 patients20) and
short follow-up (3 weeks17 and up to 3 months20 after
stroke). Furthermore, the study using the RBANS had a
similarly small sample size (n=104) and short follow-up
(13 months) and restricted the study population to those
fulfilling requirements for rehabilitation, meaning that the
study would have excluded the more severe strokes and thus
potentially those at greater risk of cognitive decline.21 When
stroke survivors were followed up for a longer period of time
(eg, ≥3 years), a significant decline in global cognition was
reported.16,18,28 Given that age is the biggest risk factor for
incident dementia,30 future studies could look at whether or
not age of onset of stroke and disease duration determines
the longitudinal cognitive trajectory after stroke. This would
involve comparing stroke cohorts that had younger onset with
an older stroke population and following their cognition over
time. This approach could help describe global cognitive
recovery in all stroke populations and assess who is at
greatest risk of cognitive nonrecovery.
When assessing domain-specific function the results were
mixed. Studies identified improvements in executive
function,20 visuospatial/constructional performance,21 and
memory (delayed)21 over 3 to 13 months of follow-up. When
participants were followed for longer periods (eg, ≥3 years),
studies reported significant decline in memory (in some
studies15,26 but not all18,23,28) and no significant change in
abstract/visuospatial performance.26 Findings were mixed for
information-processing speed, with 1 study reporting no
significant change over 3 years of follow-up24 but another
reporting significant decline over 6 years of follow-up.15 Two
studies also found no significant change in language
performance.21,26 These mixed findings could be driven by
varying sample size and heterogeneity in study design as well
as by differences in the length of follow-up and medical
treatments. These results highlight the importance of testing
different cognitive domains in stroke survivors and the need
to develop a consensus cognitive battery to allow cross-study
comparison. Further work could assess the effect of stroke
severity, subtypes, or locations on cognitive domains and
factors that could assist in cognitive recovery.
Across studies, risk factors for cognitive decline included
demographic factors (age, sex, ethnicity), neuropsychiatric
symptoms (depression), disease-related comorbidity (previous
stroke), poorer baseline cognitive tests, genetic factors (ie,
APOE*E4 status), function (balance and gait), and the nature
of the stroke itself (stroke location). Factors such as arterial
hypertension and the number of cerebral infarcts have been
shown to be prognostic variables of cognitive deterioration.31
However, not all factors were consistently observed to
increase risk, including sex and APOE*E4 status. With regard
to sex, global impairment was found to be more common in
women in 1 study,28 which is comparable to existing
literature.32 In contrast, in another study, although there
was no significant sex difference, global cognitive decline was
found to be more severe in men.25 However, this study was
performed only in older Mexican Americans and may reflect
only the relative risk found for this ethnicity. When specific
domains were tested, when stratified by sex, men were found
to show significant decline in memory.26 However, the sample
size for men was much smaller than that for women (n=27
versus n=70, respectively), which raises issues of statistical
power. Regarding APOE*E4 status, 1 study (n=19 who were
APOE genotype 4/) found a significant association between
stroke and decline in abstract/visuospatial performance in
those without the APOE*E4 allele.26 Another (n=27 APOE*E4
positive)24 found that stroke patients without the APOE*E4
allele showed faster decline on global cognition, although this
was not statistically significant and a synergistic effect was
not observed.24 In contrast, yet another study found that
being an APOE*E4 carrier was predictive of cognitive
impairment at 13 months after stroke, but again, the sample
size was small (n=25).21 Given the inconsistency of these
results with small sample sizes, further research is warranted
to identify whether APOE*E4 carriers with a history of stroke
are at a higher risk of future poststroke cognitive impairment.
A number of risk scores have been developed to predict
dementia in whole populations, with many using modifiable
risk factors (eg, vascular risk factors33,34) with the hope that
modifying these factors could alter cognitive trajectory. A risk
model approach could be used in stroke populations,
incorporating some of these variables identified in this review
to predict poststroke dementia.35 A number of risk scores
have been developed recently to predict poststroke dementia
(3 months after stroke, area under the curve: 0.74)36 and
cognitive impairment (6 months after stroke, area under the
curve: 0.83).37 Our review, however, shows that cognitive
decline seems to become more apparent over a longer follow-
up period, and thus new models could be developed to predict
poststroke cognitive impairment and dementia over longer
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time periods. Currently there are no specific biomarkers that
can help discriminate between those at risk and those with
better prognosis.38 There is evidence, however, of a strong
relationship between inflammation markers and cognitive
performance,39 and this will need further evaluation before
being used in potential risk models. Although neuroimaging
variables were used in the cognitive impairment model,37
evidence shows that data from magnetic resonance imaging do
not significantly improve prediction in all-cause dementia
models.40 Similarly, there may be less focus on incorporating
vascular risk factors into these models because results from a
recent clinical trial found that intensively managing vascular risk
factors in stroke survivors did not alter cognition after 2 years.41
Strengths and Limitations
This study has a number of strengths. We performed a
systematic search of all studies focusing on older aged
samples. Furthermore, we did not restrict our search by
cognitive domain. This is important in stroke samples, for
which overall cognitive improvement may be explained by
significant improvements in some nonmemory domains but
individuals may still show persisting memory deficits. We also
ensured that the included studies had statistical comparisons
of change in cognitive test scores over time. Nevertheless,
there are limitations. Only studies in English were included,
and the majority of studies were in white populations.
Consequently, the results may not extrapolate to nonwhite
samples. Studies were also excluded if the sample baseline
age was ≤50 years because stroke before age 50 is
uncommon, and these patients may have a different risk
profile than the older population.
Conclusions
Cognitive outcomes after stroke can be variable, and
standardized assessment tools together with recommended
time intervals for testing are needed. Determinants of
poststroke cognitive decline are important to clarify, partic-
ularly if these patients are different from the nonstroke
population; interventions may need to be tailored specifically
to stroke survivors. A number of risk factors for cognitive
decline, particularly in global functioning, in stroke survivors
have been found, such as age, sex, stroke location, and
medical comorbidities (depression), and could be incorpo-
rated into a risk tool to identify stroke survivors at highest risk
of cognitive decline over short and long durations of follow-up.
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 Table S1. Study Characteristics  
Author, 
Year 
Data Resource Demographic Data Frequency and Timing of Cognitive Assessment Stroke Cases 
and Definition 
Reported 
Comijs 
20091 
LASA, population based 
study, the Netherlands (50 
T1, 90 T2, 84 T3) 
Mean age (total sample)=72.1 
(Range: 55-85) 
Mean education (total 
sample)=9.0 years 
Male 51.5% (total sample)  
 
Up to six years 
Time 1 = 1992-93, Time 2 = 1995-96, Time 3 = 1998-99 
Self-reported  
Rajan 
20142 
Chicago Health and Aging 
Project 
 
Baseline n=1187 
Mean age=73.7 years (SD=6.3) 
Mean (SD) 
Mean education=12.0 years 
(SD=3.4) 
Male 41% 
 
Mean follow-up time after incident stroke was 4.2 years (SD=3.9).  Self-report 
ischaemic and 
haemorrhagic 
 
 
Ghosal 
20143 
Urban community in 
Kolkata 
 
3 annual visits, baseline 
year (n = 283), first follow-
up (n = 220), second 
follow-up (n = 181), third 
follow-up (n = 159) 
Mean age (SD): 64.27 +/- 13.08 
years 
Male 51.9% 
Female 48.9% 
Mean education (SD): 5.42 +/- 
4.84 years 
Bengali versions of the Mini Mental State Examination (BMSE); Baseline 
and 3 annual follow-up visits 
Cases initially 
screened by 
field workers 
using a 
validated 
WHO-based 
questionnaire. 
Screened 
patients were 
further 
examined by 
field 
physicians and 
the findings 
reviewed by 
senior 
neurologists.  
 
WHO 
definition 
Levine 
20134 
Sacramento Area Latino 
Study on Aging (SALSA 
cohort) (1576, 151 with 
Male (n=655, mean age=70.2, 
SD=6.7);  
 
Yearly for ten years. Incident first-ever stroke mean years of follow-up: 
women 3.6 years, 3.4 for men 
Participant 
self-report of a 
physician 
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incident first-ever stroke 
during ten years of follow-
up) 
Female (n=921, mean age=70. 
 
Incident first-ever stroke: 72 +/- 8 
years 
655 Males, 921 Females. Incident 
first-ever stroke: 66 men, 85 
women 
 
Male (n=655, mean education 
=8.0 years, SD=5.6); Female 
(n=921, mean education =6.9 
years, SD=5.1); Education: First-
ever stroke: male 7.6 (SD 5.6) 
years, female 7.0 (SD 5.9 years) 
diagnosis 
during 
following up or 
stroke as cause 
of death on 
death report 
Reitz 
20065 
Longitudinal study of 
Medicare recipients in 
northern Manhattan (1271 
(Stroke cases = 97)) 
Mean age = 76.2 years, SD=6.0  
69.6% female 
Mean education = 8.6 yrs, 
SD=4.6 
Baseline data (1992-1994), follow up data during sequential intervals of 
approximately 18 months (1994-1996, 1996-1997, 1997-1999) – 5 year 
interval.  
Participant/ 
informant 
interview; 
confirmed by 
medical 
records (85% 
included brain 
imaging), 
remainder by 
direct exam 
 
WHO criteria 
Suzuki 
20136 
First round: 57, Second 
round 43 
First round mean age 73.5 years 
(SD 9.3) Second round mean 72.4 
(SD 10.8) 
First round Female 56.1%  
Second round Female 55.8% 
 
Initial assessment from onset of stroke (baseline assessment) and then at 1 
week (second set of assessments) and 2 weeks (third set of assessments) 
after the baseline assessment. 
 
Second round of data collection: baseline assessment and at 1, 2,  
and 3 weeks after the baseline assessment in each individual. 
NOT 
REPORTED 
Ben 
Assayag 
20157 
Tel Aviv Brain Acute 
Stroke Cohort 
(TOBASCO) Study (n – 
298) 
Mean age 66.7+/-9.6 years 
62.4% male (n = 186) 
Mean education 13.2 (SD 3.7) 
years 
Baseline MoCA and NeuroTrax computerised cognitive testing and then 
repeated at 6, 12 and 24 months following the event. The average of the 6 
index scores (memory, executive functions, visuospatial perception, verbal 
function, attention and motor skills) was computed as the global cognitive 
score.  
Mild to 
moderate first-
ever acute 
ischaemic 
stroke 
Tene 
20168 
Tel Aviv Brain Acute 
Stroke Cohort 
(TOBASCO) Study 
Mean age (SD): 67.1 (10.0) 
years) 
n (%) males 182 (59.5) 
Baseline MoCA and NeuroTrax computerised cognitive testing and then 
repeated at 6, 12 and 24 months following the event. The average of the 6 
index scores (memory, executive functions, visuospatial perception, verbal 
Mild to 
moderate first-
ever acute 
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Baseline = 306, 6, 12 and 
24 month follow-up 
Mean education (SD): 13.2 (3.7) 
years 
function, attention and motor skills) was computed as the global cognitive 
score.  
ischaemic 
stroke 
Toole 
20049 
Population based cohort 
(Cardiovascular Health 
Study) (n = 5364) 
≥65  
 
Follow-up visits between 1992- 1998 Self-report and 
confirmed by 
medical record 
Kohler 
201210 
Ageing, Cognition and 
Dementia in Primary Care 
patients (AgeCoDe), 
Germany (3214 at baseline, 
321 cases) 
Mean age (total sample)=79.7 
(SD=3.6, range: 75-98) 
Education (as measured by the 
Comparative Analysis of Social 
Mobility in Industrial Nations 
classification): 
Low (1988) 61.9% 
Middle (883) 27.5% 
High (343) 10.7% 
Male 34.5% (total sample) 
 
Three follow-ups, every 18 months after baseline (between 2003 – 2009) 
 
 
Primary care 
based records - 
stroke or TIA 
Rowan 
200711 
N = 126 Median age=79.4 years 
Males – n=94 (55.3%) 
 
3, 15 and 27 months post stroke Clinical and 
CT scan 
evidence-based 
diagnosis of 
stroke 
 
Oxford 
community 
Stroke Project 
classification 
Dik 
200012 
LASA, the Netherlands 
 
1,224 in total sample, 53 
stroke patients 
 
Age Range 65-85 years 
 
Stroke (n=53, Mean=74.6 years, 
SD=6.7). 
 
Stroke (male=37, 69.8%).  
 
Stroke (Mean education =8.5 yrs, 
SD=3.4).  
 
  
 
 
 
Mean follow-up=3.1 (SD=0.2) years GP diagnosis 
of stroke. 
When GP 
diagnosis not 
available 
participant 
self-report 
(n=211) 
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Leeds 
200113 
Admissions to stroke 
rehabilitation unit (n = 83) 
60+ years (Mean age=75.4 years, 
SD=8.1) 
44 male, 39 female 
1 month (mean=4.14 weeks, range 1-5 weeks) and 3 months post stroke 93 stroke 
confirmed by 
CT scan; rest 
based on 
clinical history 
and physical 
examination 
Wagle 
201014 
Admissions to stroke 
rehabilitation unit of 
Ulleval University Hospital 
(Oslo, Norway) (n = 104) 
Cognitive impairment group 
(n=52, age mean=81.0 SD=9.5). 
 
No cognitive impairment group 
(n=52, age mean=78.0 SD=20.3) 
 
Cognitive impairment group 
(n=52, females=23, 44%). 
 
No cognitive impairment group 
(n=52, females=25, 47%) 
 
Cognitive impairment group 
(n=52, Mean education =11.0 
years SD=5.0). 
 
No cognitive impairment group 
(n=52, Mean education =11.0 
years SD=3.8) 
12-15 months post stroke (Mean=408.4 days, SD= 41.2)  Ischemic or 
hemorrhagic 
 
Abbreviations 
ACT, Alphabet Coding Task; AD, Alzheimer’s Disease; ADL, Activities of Daily Living; AVLT, Auditory Verbal Learning Test; BMSE, Bengali versions of the Mini 
Mental State Examination; CAMCOG, Cambridge Cognitive Assessment; Cambridge Cognitive Assessment ; CAMCOG-R, Cambridge Cognitive Assessment; 
Cambridge Cognitive Assessment (Revised); CERAD, Consortium to Establish a Register for Alzheimer’s Disease; COGFAST, Cognitive Function After Stroke; CT, 
Computed Tomography; DSM, Diagnostic and Statistical Manual of Mental Disorders; GP, General Practitioner; LACI, Lacunar infarct; LASA, Longitudinal Aging 
Study Amsterdam; M, Mean; MMSE, Mini Mental State Examination; MoCA, Montreal Cognitive Assessment; MRC, Medical Research Council; NIHSS, National 
Institutes of Health Stroke Scale; PACI, Posterior anterior circulation infarct; POCI, posterior circulation infarct; RCPM, Raven’s Colored Progressive Matrices; SD, 
Standard Deviation; TIA, transient ischaemic attack; WAIS-R, Wechsler Adult Intelligence Scale-Revised; WHO, World Health Organisation 
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Table S2 Baseline and Follow-up Cognitive Measures 
Author, 
Year 
Baseline Measures Follow-up Measures Grouped Results and Outcome 
Comijs 
20091 
Mean (±SD) 
 
General Cognitive 
Functioning (MMSE): 
T1 27.5±2.0 
Fluid Intelligence 
T1 18.0±3.9 
Information processing 
speed 
T1 24.3±6.9 
Immediate AVLT  
T1 7.7±2.5 
Delayed AVLT 
T1 5.1±2.6 
Mean (±SD) 
 
General Cognitive Functioning (MMSE): 
T2 27.2±2.4 
T3 27.2±2.4 
Fluid Intelligence 
T2 17.6±4.0 
T3 17.2±4.0 
Information processing speed 
T2 23.3±7.1 
T3 23.2±6.9 
Immediate AVLT  
T2 8.0±2.7 
T3 7.7±2.7 
Delayed AVLT 
T2 5.7±3.0 
T3 5.3±2.9 
Interactions between time and stroke (mean differences in cognitive function) 
between those with and those without stroke 
 
Information processing speed (ACT)  
T1 -1.08, T2 -2.78, T3 -3.40 (p <0.05) 
 
Immediate Recall (AVLT) 
T1 0.01, T2 -0.35, T3 -0.72 (p<0.04) 
 
Delayed Recall (AVLT) 
T1 0.10, T2 -0.41, T3 -0.92 (p<0.005) 
 
MMSE β=-0.26 (-0.69/0.16); RCPM β=-0.73 (-1.32/-0.14); ACT β=-1.97 (-
2.78/-1.16); AVLT (immediate) b=-0.44 (-0.83/-0.06); AVLT (delayed) β=-0.56 
(-0.95/-0.17) 
 
Compared to no-stroke, stroke had a higher rate of decline for information 
processing speed (p=0.05) and memory (immediate p=0.04, delayed p=0.005) 
Rajan 
20142 
MMSE Mean (SD): 26.3 
(4.2) 
 
Delayed recall Mean (SD): 
7.7 (3.0) 
 
Immediate recall Mean 
(SD): 8.3 (2.6) 
 
Symbols digit Mean (SD): 
28.4 (13.7) 
 
Composite measure of 4 
tests Mean (SD): 0.142 
(0.753) 
 
 
NOT REPORTED Cognitive function decline increased by 0.058 units/year after incident stroke.  
 
Cognitive decline increased significantly after stroke relative to before stroke.  
 
Cognitive decline increased 1.9 fold after incident stroke with cognitive function 
predicting mortality even after adjusting for stroke, demographic and health 
related factors. 
Kohler 
201210 
No reported stroke only 
outcomes 
NOT REPORTED Verbal fluency (estimate, p-value): intercept -0.919, 0.002 slope -0.219, 0.56;  
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 Verbal fluency: M=19.5, 
SD=5.4. (Not stroke or 
TIA specific)  
 
Immediate recall: M=18.6, 
SD=4.0. (Not stroke or 
TIA specific) 
 
Delayed recall: M=5.4, 
SD=2.2. (Not stroke/TIA 
specific) 
Immediate recall (estimate, p-value): intercept -0.641, 0.003; slope -0.532, 0.09  
 
Delayed recall (estimate, p-value): intercept -0.311, 0.01; slope -0.062, 0.68 
 
Ghosal 
20143 
BMSE (n = 254) - mean 
(SD) 
26.48 +/- 3.4 
BMSE mean (SD) 
Year 1 (n = 197) 
26.81 +/- 3.11 
 
Year 2 (n = 161) 
26.45 +/- 3.75 
 
Year 3 (n = 141) 
25.89 +/- 4.66 
BMSE Coefficient time (standard error) over 3 years = -0.2061 (0.0937) (p = 
0.028) 
 
Cognitive dysfunction was associated with negative outcome regarding mood 
state affecting both basic and instrumental activities of daily living. Education 
was inversely related to cognitive status. Neuropsychiatric (depression and 
cognition), socioeconomic (lower educational level), demographic (female sex), 
and cultural factors can adversely affect outcome in stroke survivors. 
Levine 
20134 
3MSE: men mean =83.3 
(SD 12.1), women M=85.1 
(SD 11.8)  
Word list delayed recall: 
men mean=7.0 (SD 2.9) 
women M=8.7 (SD 3.0) 
3MSE errors increased by 22%/year in men 
(95% CI, 6.8% - 36.7%) and 13.2%/year in 
women (95% CI, 3.5% - 22.9%) 
 
Word list improved by 0.05 words/year 
(95% CI -0.24 - 0.33) in men and by 0.09 
words/year (95% CI -0.16 - 0.34) 
Parameter (SE), p value. 
3MSE 
Men 
Model A 
post-stroke intercept: 0.60 (0.39), non-significant  
post stroke by time interaction term: 0.17 (0.06), p<=0.01 
post stroke change per visit: 0.20 (0.06), p<=0.01 
 
Model B 
post-stroke intercept: 0.29 (0.38), non-significant  
post stroke by time interaction term: 0.16 (0.06), p<=0.01 
post stroke change per visit: 0.17 (0.06), p<=0.01 
 
Women 
Model A 
post-stroke intercept: 0.71 (0.39), p<=0.05  
post stroke by time interaction term: 0.09 (0.04), p<=0.05 
post stroke change per visit: 0.12 (0.04), p<=0.01 
 
Model B 
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post-stroke intercept: 0.49 (0.28), non-significant  
post stroke by time interaction term: 0.12 (0.04), p<=0.01 
post stroke change per visit: 0.13 (0.04), p<=0.01 
 
Model A: included baseline age and years of education, time varying depressive 
symptoms (CES-D scores), time varying incident stroke, time and the incident 
stroke by time interaction term.  
 
Model B added time-varying systolic BP to model A. 
 
MMSE: 3MSE errors increased by 2.4% per year in men and increased by 3.3& 
per year in women. Post stroke changes in 3MSE errors were statistically 
significant in both men and women. Over the post stroke period 3MSE errors 
increased by 22% per year in men and by 13.2% per year in women. 
 
Changes in word list scores post-stroke were not statistically significant in either 
sex. However, the magnitude of post-stroke change in word list scores was 1.7 
times larger in women than in men.   
Dik 
200012 
Mean MMSE 26.5 
 
Mean Immediate recall 6.8 
 
Mean delayed recall 4.1 
 
Mean information 
processing speed 20.2 
No scores published but percentage that 
declined reported: 
Decline in MMSE % 28.3% 
 
Decline in Immediate recall 11.8% 
 
Decline in delayed recall % 19.6 
 
Decline in information processing speed % 
18.8 
Odds Ratio (95% CI) for Stroke patients (adjusted for age, sex, education, 
baseline cognition score) 
MMSE 1.9 (1.0-3.7) 
Immediate Recall 0.7 (0.4 – 1.6) 
Delayed Recall 1.4 (0.7 – 2.9) 
Information processing speed 1.2 (0.7 – 2.1) 
 
APOE e4 carriers demonstrated a non-significantly lowered risk for MMSE 
decline. APOE e4 associated with declines in info processing speed and small 
declines for immediate and delayed recall. Of the 53 stroke patients - (n=17) had 
the e4 allele for APOE, (n=36) did not. Stroke patients without ApoE e4 had the 
lowest changes in MMSE (-1.6 points). Stroke patients with e4 showed greater 
declines in info processing speed (-2.0 points). 
Reitz 
20065 
NOT REPORTED NOT REPORTED Memory declined significantly over time (β= -1.6, p=0.005), 
abstract/visuospatial and language performance remained stable. A history of 
stroke was associated with more rapid decline in memory performance over time 
(β=-3.6, p=0.04). There was no relation between stroke and decline in 
abstract/visuospatial or language performance. 
 
Memory and abstract/visuospatial function declined at a faster rate in men or 
persons who lacked the APOEe4 allele with stroke compared to women or 
APOEe4 carriers. This remain unchanged after adjusting for age, education, 
ethnic group, BMI< hypertension, heart disease, diabetes and smoking. 
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 The association between stroke and decline in memory performance was 
strongest for men and for persons without an APOE4 allele. A significant 
association between stroke and decline in abstract/visuospatial performance was 
also observed for persons without the APOE-e4 allele. 
Suzuki 
20136 
MMSE at baseline First 
round: median 23 (IQR: 17 
- 25), Second round: 
median 23 (IQR 20 - 25) 
MMSE (second round): third assessment (2 
weeks) - Median 24 (IQR 22 - 27), fourth 
set of assessments median 25 (IQR 23-28) 
Third set of Assessments 
Predicted MMSE Score (logarithmic model) median 25 (IQR 22-27), model fit 
0.68 (P<0.0001 for difference between actual and predicted values).  
 
Predicted MMSE score (linear regression model): median 25 (IQR 22-28), 
Model fit 0.60 (P<00001 for difference between actual and predicted values 
(linear regression analysis) 
Ben 
Assayag 
20157 
Mean (SD) (Baseline) 
All participants: MoCA 
23.9 (3.3) 
Cognitively intact at 2 
years: 24.3 (3.1) 
Cognitive Decline 2 years 
after stroke: 21.8 (3.6) 
 
Mean (SD) (Baseline) 
All participants: 
Computerised global 
cognitive score 92.5 (14.1) 
Cognitively intact at 2 
years: 93.6 (13.7) 
Cognitive Decline 2 years 
after stroke: 86 (15.2) 
Mean (SD) (6 months) 
All participants: MoCA 25.3 (3.3) 
Cognitively intact at 2 years: 25.7 (3) 
Cognitive Decline 2 years after stroke: 22.9 
(3.9) 
 
Mean (SD) (6 months) 
All participants: Computerised global 
cognitive score 94.8 (12.4) 
Cognitively intact at 2 years: 96.1 (11.8) 
Cognitive Decline 2 years after stroke: 87 
(13.5) 
Cognitive scores 6 months after stroke/TIA (23.9±3.3 versus 25.3±3.3, P<0.001 
for the Montreal cognitive assessment scores; 92.5±14.1 versus 94.8±12.4, 
P<0.001 for the computerized global cognitive score 
 
Univariate predictors of cognitive decline 24 months from stroke include: age 
greater than or equal to 75, education <12 years, white matter lesion score, 
Modified Rankin score 6 months after stroke, MoCA score at hospital admission, 
MoCA score 6 months after stroke, Berg Balance Scale 6 months after stroke 
(<50), the Timed Up and Go test score 6 months after stroke (>12 seconds), 
number of correct answers during dual-task 6 months after stroke (<15). 
Multivariate predictors include age greater than or equal to 75 years, TUG score 
(> 12secs) 6 months after stroke, MoCA score 6 months after stroke 
 
Balance and gait are significant risk markers for cognitive status and impaired 
cognitive recovery after mild stroke or TIA 
Tene 
20168 
Mean (SD) (Baseline) 
All participants: MoCA 
23.8 (3.3) 
GDS < 6: 23.8 (3.4) 
GDS > or equals 6: 23.5 
(3.2) 
 
Mean (SD) (Baseline) 
All participants: 
Computerised global 
cognitive score 91.8 (14.1) 
GDS <6: 91.9 (14.6) 
Mean (SD) (6 months) 
All participants: MoCA 25.0 (3.7) 
GDS < 6: 25.1 (3.5) 
GDS > or equals 6: 24.2 (4.6) 
 
Mean (SD) (6 months) 
All participants: Computerised global 
cognitive score 94.1 (12.5) 
GDS <6: 94.8 (12.1) 
GDS > or equals 6: 89.4 (14.1) 
Univariate predictors of cognitive decline 24 months from stroke include: age 
greater or equal to 75 years, education <12 years, ischaemic heart disease, 
hypertension, white matter lesion score, MoCA score at hospital admission, 
MoCA score 6 months after stroke Computerised global cognitive score at 
admission and 6 months post-stroke, GDS score at admission and 6 months 
posts-stoke. Multivariate predictors include MoCA at admission, age greater or 
equal to 75 and admission GDS score greater than or equal to 6 
 
Depressive symptoms in poststroke/TIA patients are associated with MCI or 
dementia and functional deterioration at 2-year follow-up. This association 
occurs immediately after stroke/TIA and becomes more significant 6 months 
after the initial stroke. 
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GDS > or equals 6: 91.3 
(9.3) 
Leeds 
200113 
CAMCOG-R 
 
Baseline 
TOTAL: 79.5 (median), 
mean 77.8 (SD 13.8) 
 
EF: 14.0 (median), mean 
13.1 (SD 4.7) 
 
EX: median 5.0, mean 5.1 
(SD 2.6) 
 
 
Follow-up – significant improvement in all 
three mean scores: 
TOTAL: 83.14 (SD 12.2) 
EF 14.6 (SD 4.9) 
EX 5.8 (SD 2.5) 
Depression influenced the performance on executive function tests as well as the 
overall CAMCOG-R score. 
Wagle 
201014 
RBANS total scale score at 
baseline (median (IQR)):  
n=104, total score baseline 
73 (20). 
 
(Cognitive impairment 
according to RBANS Total 
Index Score was defined as 
a score <= 77.5 points, 
equal to 1.5 SD below 
mean which is 
recommended cut-off 
score for MCI. 
 
MMSE score at baseline 
(median (IQR)): n=104. 
MMSE=25 (7) 
 
RBANs index score 
(individual tests) (median 
(IQR)): 
Immediate memory 89 
(25) 
Visuospatial/constructional 
82 (34) 
Language 76 (22) 
RBANS total scale score at 13 months 
follow up (median (IQR)):  
n=104, total score follow up 78 (29) 
(p=0.001) 
 
MMSE score at 13 months follow up 
(median (IQR)): n=104. MMSE=25 (9) 
 
RBANS index score (individual tests) at 13 
months (median (IQR)): 
Immediate memory 89 (39) 
Visuospatial/constructional 94 (45) 
Language 82 (25) 
Attention 65 (18) 
Delayed memory 83 (29)  
 
Significant differences found for 
visuospatial (p<0.001), delayed memory 
(p=0.034) 
 
APOEe4-negative RBANS index scores at 
13 months (median (IQR)) 
Immediate memory 91.0 (36.0) 
Visuospatial/constructional 97.0 (46.0) 
Language 84.0 (25.0) 
Attention 70.0 (21.0) 
Of the n=104, 61 (59%) were classified as cognitively impaired at baseline, 
compared to 52 (50%) at follow up. In total, 45 were classed as cog. Impaired at 
both occasions (persistent cases), 7 of the non-impaired at baseline switched to 
impaired at follow up, 16 were classed as cognitively impaired at baseline but 
switched to non-impaired at follow up (recovery cases) 
 
A significant dose-dependent effect of the APOE-genotype in relation to overall 
post-stroke cognitive functioning was found at baseline and follow-up, but not 
pre-stroke. The e4 carriers showed a significant decline in tests related to verbal 
learning and memory compared to the non-carriers. 
 
Four factors at baseline were independently associated with cognitive 
impairment at 13 months after acute stroke:  
 
Previous stroke, higher IQCODE score (indicating poorer pre-stroke cognitive 
functioning), higher NIHSS score (indicating more severe strokes) and the 
presence of one or two e4-alleles. 
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Attention 70 (18) 
Delayed memory 82 (22) 
 
APOEe4-negative RBANS 
index scores (median 
(IQR)) 
Immediate memory 94.0 
(23.0) 
Visuospatial/constructional 
82.0 (33.0) 
Language 82.0 (23.0) 
Attention 70.0 (18.0) 
Delayed memory 85.0 
(23.0) 
Total scale 77.0 (21.0) 
 
APOEe4 positive RBANs 
index score (median 
(IQR)) 
Immediate memory 83.0 
(25.0) 
Visuospatial/constructional 
78.0 (27.5) 
Language 71.0 (16.5) 
Attention 65.0 (11.5) 
Delayed memory 76.0 
(14.5) 
Total scale 65.0 (11.5) 
 
APOEe4-negative MMSE 
(median (IQR)) 
Total 25.0 (7.0) 
Orientation for time 4.0 
(2.0) 
Orientation for place 5.0 
(1.0) 
 
APOEe4-positive MMSE 
(median (IQR)) 
Total 26.0 (8.0) 
Orientation for time 4.0 
Delayed memory 91.0 (29.0) 
Total scale 83.0 (32.0) 
 
APOEe4 positive RBANs index score 
(median (IQR)) 
Immediate memory 77.0 (27.0) 
Visuospatial/constructional 85.0 (44.5) 
Language 71.0 (25.0) 
Attention 62.0 (8.0) 
Delayed memory 71.0 (16.5) 
Total scale 62.0 (17.0) 
 
APOEe4-negative MMSE at 13 months 
(median (IQR)) 
Total 26.0 (8.0) 
Orientation for time 5.0 (2.0) 
Orientation for place 5.0 (1.0) 
 
 
APOEe4-positive MMSE (median (IQR)) 
Total 22.0 (12.3) 
Orientation for time 2.5 (4.0) 
Orientation for place 5.0 (1.0) 
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(2.0)  
Orientation for place 5.0 
(2.0) 
Toole 
20049 
NOT REPORTED NOT REPORTED Participants with a history of stroke (model 0: adjusted for 3MS) had an 
annualised loss of 1.6 (95% confidence interval -2.1, -1.1) points per year more 
than those without previous stroke. 
 
Participants with baseline stroke (model 1: adjusted for prior 3MS, age, sex, 
race, education, income, smoking, hypertension, antihypertensive and 
antidepressant medication use, prior diabetes and prior coronary heart disease) 
had an average 3MS decline of 1.2 (95% confidence interval [CI]:  0.7- 1.7) 
points per year more than those without one. 
 
Results demonstrate that the rate of cognitive decline after ischemic stroke is 
more than double that of individuals without one. In addition, a recent left 
hemisphere stroke causes decline 10 times as great as that experienced by 
persons without one and 60% more rapid than that of persons with a recent 
stroke in the right hemisphere. 
Rowan 
200711 
Total group 
CAMCOG 86.6 (7.9) 
Executive function 14.7 
(4.6) 
Language expression 16.9 
(2.0) 
Power of attention 1.8 
(0.7) 
 
Total CAMCOG at 3 
months post-stroke, study 
group by quartile 
homocysteine level 
Lowest 86.6 (8.3) 
2nd 86.5 (8.1) 
3rd 87.8 (8.3) 
Highest 85.7 (6.6) 
 
Executive function at 3 
months post-stroke, study 
group by quartile 
homocysteine level 
Lowest 15.1 (15.1) 
Total group (mean changes (SD) between 3 
and 27 months post stroke) 
CAMCOG -0.6 (7.8) 
Executive function -2.1 (4.7) 
Language expression -0.4 (1.8) 
Power of attention 0.1 (0.4) 
 
Total CAMCOG (mean changes (SD) 
between 3 and 27 months post stroke) 
Lowest -2.3 (8.4) 
2nd 1.1 (8.4) 
3rd -0.2 (6.8) 
Highest -1.7 (7.4) 
 
Executive function (mean changes (SD) 
between 3 and 27 months post stroke) 
Lowest -2.6 (4.3) 
2nd -2.3 (5.9) 
3rd -1.5 (3.6) 
Highest -1.7 (4.5) 
 
Language expression (mean changes (SD) 
between 3 and 27 months post stroke) 
51% of elderly non-demented stroke patients have hyperhomocysteinaemia at 3 
months post stroke. 79% of elderly stroke patients scored above 80 points on the 
CAMCOG at 27 months post stroke. 
 
Found no associations between homocysteine levels and cognitive change, 
therefore 3 month post-stroke homocysteine measurement may not predict 
cognitive decline 
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2nd 14.1 (5.3) 
3rd 15.0 (4.4) 
Highest 14.5 (3.6) 
 
Language expression at 3 
months post-stroke, study 
group by quartile 
homocysteine level 
Lowest 17.1 (2.0) 
2nd 16.9 (2.2) 
3rd 17.2 (1.6) 
Highest 16.6 (2.0) 
 
Power of Attention at 3 
months post-stroke, study 
group by quartile 
homocysteine level 
Lowest 1.7 (0.5) 
2nd 1.8 (0.7) 
3rd 1.7 (0.5) 
Highest 1.9 (0.9) 
Lowest -0.5 (1.7) 
2nd -0.3 (1.9) 
3rd -0.2 (2.0) 
Highest -0.5 (1.4) 
 
Power of Attention (mean changes (SD) 
between 3 and 27 months post stroke) 
Lowest 0.1 (0.4) 
2nd 0.1 (0.6) 
3rd 0.1 (0.4) 
Highest 0.0 (0.3) 
 
Abbreviations 
3MS, modified mini mental; 3MSE, modified mini mental examination; ACS, acute coronary syndrome; ACT, Alphabet Coding Task; ADL, activities of daily living; 
aMCI, amnestic mild cognitive impairment; AVLT, Auditory Verbal Learning Test; BMI, body mass index; BMSE, Bengali versions of the Mini Mental State 
Examination; CAMCOG-R, Cambridge Cognitive Assessment; Cambridge Cognitive Assessment (Revised); CES-D, Center for Epidemiologic Study-Depression; CI, 
Confidence interval; EF, Total executive functioning subtests of the CAMCOG-R (fluency + similarities+ ideational fluency + visual reasoning); CERAD, Consortium to 
Establish a Register for Alzheimer’s Disease; EX, New executive functioning tests (ideational fluency + visual reasoning); FIM, functional independence measure; GDS, 
Geriatric Depression Score; IQCODE, Informant questionnaire on Cognitive Decline in the Elderly; IQR, interquartile range; LACS, Lacunar stroke; MCI, mild cognitive 
impairment; MMSE, Mini Mental State Examination; MoCA, Montreal Cognitive Assessment; OCSP, The Oxfordshire Community Stroke Project; OR, odds ratio; 
PACS, Partial anterior circulation stroke; POCS, Posterior circulation stroke; Repeatable Battery for the Assessment of Neuropsychological Stats (RBANS); RCPM, 
Raven’s Colored Progressive Matrices; SD, Standard Deviation; SE, standard error; SFE, social functioning exam; TACS, Total anterior circulation stroke; TIA, transient 
ischaemic attack; TUG, Timed Up and Go 
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